Modulators of cystic fibrosis transmembrane conductance regulator
The present invention features a compound of formula (I): (I) or a pharmaceutically acceptable salt thereof, where R
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
04.05.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention features a compound of formula (I): (I) or a pharmaceutically acceptable salt thereof, where R |
---|---|
Bibliography: | Application Number: AU20150328174 |